XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 17,893 $ 2,416
Marketable securities, available for-sale 84,777 25,718
Incentive and tax receivables 3 154
Prepaid expenses and other current assets 1,645 202
Deferred offering costs 0 1,398
Total current assets 104,318 29,888
Property, plant and equipment-net 780 444
Total assets 105,098 30,332
Current liabilities:    
Accounts payable 10,114 8,606
Accrued liabilities 726 1,939
Other current liabilities 255 489
Total current liabilities 11,095 11,034
Other liabilities 85 276
Total liabilities 11,180 11,310
Commitments and Contingencies 0 0
Convertible preferred stock, $0.01 par value, no shares authorized, issued or outstanding as of September 30, 2021; 11,260,608 shares authorized, issued and outstanding as of December 31, 2020: aggregate liquidation preference of $70,254 as of December 31, 2020 73,037
Stockholders' (deficit) equity:    
Common stock, $0.01 par value; 200,000,000 shares authorized, 40,053,157 and 12,767,909 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively Additional paid-in-capital 401 71
Additional paid-in-capital 167,440 1,633
Accumulated other comprehensive income 131 10
Accumulated deficit (74,054) (55,729)
Total stockholders' equity (deficit) 93,918 (54,015)
Total liabilities, convertible preferred stock and stockholders' equity (deficit) $ 105,098 $ 30,332